Skip to main content

Animations

MJFF Publications

1651 - 1660 of 9156 Results
Title
Year
  • Year
  • 2012
  • 2012
  • 2012
  • 2013
  • 2010
  • 2023
  • 2023
  • 2023
  • 2023
  • 2016
  • Summary Details
    OPEN
    Title: SIRT2 as a Therapeutic Target for Age-Related Disorders
    Journal Name: Frontiers in Pharmacology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fphar.2012.00082
    Citation Count: 139
  • Summary Details
    OPEN
    Title: TMBIM3/GRINA is a novel unfolded protein response (UPR) target gene that controls apoptosis through the modulation of ER calcium homeostasis
    Journal Name: Cell Death & Differentiation
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/cdd.2011.189
    Citation Count: 85
  • Summary Details
    OPEN
    Title: Inhibition of Drp1 provides neuroprotection in vitro and in vivo
    Journal Name: Cell Death & Differentiation
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/cdd.2012.18
    Citation Count: 337
  • Parkinson‘s Disease: What Role Do Pedunculopontine Cholinergic Neurons Play?
    2013
    Summary Details
    RESTRICTED
    Title: Parkinson‘s Disease: What Role Do Pedunculopontine Cholinergic Neurons Play?
    Journal Name: Future Neurology
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.2217/fnl.13.61
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Bid-mediated mitochondrial damage is a key mechanism in glutamate-induced oxidative stress and AIF-dependent cell death in immortalized HT-22 hippocampal neurons
    Journal Name: Cell Death & Differentiation
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/cdd.2010.92
    Citation Count: 189
  • Summary Details
    OPEN
    Title: Reduced and Delayed Cerebrovascular Reactivity in Patients with Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.29429
    Citation Count: 21
  • Summary Details
    OPEN
    Title: Long‐Read Sequencing Resolves a Complex Structural Variant in PRKN Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.29610
    Citation Count: 34
  • Summary Details
    OPEN
    Title: Reply to: Comment on “Summing MDS‐UPDRS Parts 1 + 2 (Non‐motor and Motor Experience of Daily Living): The Patient's Voice”
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.29513
    Citation Count: 0
  • Summary Details
    OPEN
    Title: A Double‐Blind, Randomized, Placebo‐Controlled Trial of Ursodeoxycholic Acid (UDCA) in Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.29450
    Citation Count: 65
  • Summary Details
    OPEN
    Title: Characterization of a novel adeno-associated viral vector with preferential oligodendrocyte tropism
    Journal Name: Gene Therapy
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/gt.2016.62
    Citation Count: 93
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.